Up Day as Wall Stre...
Health Care: Drugs
ACADIA Pharmaceuticals Inc. (ACAD: NASDAQ)
$18.43 -0.49 | -2.59%
06/18/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 4.91M | 2.07M | 42.14M | 6.40M |
| Cost of Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 4.91M | 2.07M | 42.14M | 6.40M |
| Selling, General, and Administrative Expenses | 7.00M | 7.61M | 6.46M | 10.28M |
| Research & Development | 18.79M | 17.31M | 20.58M | 41.58M |
| Operating Income before D & A (EBITDA) | -20.89M | -22.85M | 15.09M | -45.47M |
| Depreciation & Amortization | -24.00K | 390.00K | 607.00K | 1.11M |
| Interest Income | 37.00K | 87.00K | 45.00K | 409.00K |
| Other Income - Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -20.82M | -23.16M | 14.53M | -46.17M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 86.00K |
| Pre-Tax Income | -20.82M | -23.16M | 14.53M | -46.26M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -20.85M | 0.00 | 0.00 | 0.00 |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -20.85M | 0.00 | 0.00 | 0.00 |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -20.85M | -22.76M | 15.14M | -45.14M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-20.85M | 0.00 | 0.00 | 0.00 |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -20.85M | 0.00 | 0.00 | 0.00 |
| Basic EPS from Continuing Ops. | -0.38 | -0.44 | 0.39 | -1.20 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.38 | -0.44 | 0.39 | -1.20 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.38 | -0.44 | 0.39 | -1.20 |
| Basic Normalized Net Income/Share | -0.38 | n.a. | n.a. | n.a. |
| EPS fr Continuing Ops. | -0.38 | -0.44 | 0.39 | -1.20 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.38 | -0.44 | 0.39 | -1.20 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.38 | -0.44 | 0.39 | -1.20 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.38 | n.a. | n.a. | n.a. |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ACAD
- Portfolio NameUser Type
- ContributorFive Best-Performing Biotec...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserDividend Portfolio
- UserWatch
- ContributorBreakout Stocks Of The Week...
Latest ACAD Headlines from TheStreet
- ACADIA Stock Falls On Unusually High Volume (ACAD) 04.12.13 | 10:04 am
- Cramer's 6 Stocks in 60 Seconds: UA ADBE FTNT ACAD CELG RLGY (Update 1) 04.11.13 | 05:04 pm
- Stocks Ramp-Up on Encouraging Jobs Report 04.11.13 | 04:04 pm
- 5 Stocks Under $10 Set to Soar Higher 04.11.13 | 02:04 pm
- Acadia Plans Early FDA Filing Of Parkinson's Drug 04.11.13 | 07:04 am
- 'Mad Money' Lightning Round: Acadia Pharmaceuticals Is a Buy 04.05.13 | 06:04 am
- TheStreet Ratings Top 10 Rating Changes 04.01.13 | 11:04 am
- ACADIA Pharmaceuticals Inc. Stock Downgraded (ACAD) 03.28.13 | 05:03 am
- 'Mad Money' Lightning Round: Blackstone Is a Buy 03.23.13 | 06:03 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 03.22.13 | 07:03 pm
Press Releases for ACAD
- Over $400 Million Raised By U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings In 2012, Reports Brinson Patrick - PR Newswire 04.08.13 | 08:04 am
- ACADIA Announces Presentation Of Data From Its Pivotal Phase III Parkinson’s Disease Psychosis Study With Pimavanserin At The American Academy Of Neurology Annual Meeting - Business Wire 03.20.13 | 10:03 pm
- ACADIA Pharmaceuticals To Present At The 25th Annual ROTH Conference On March 19, 2013 - Business Wire 03.13.13 | 09:03 am
- ACADIA Pharmaceuticals Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012 - Business Wire 03.12.13 | 04:03 pm
- ACADIA Pharmaceuticals To Announce Fourth Quarter And Full Year 2012 Financial Results On March 12, 2013 - Business Wire 03.05.13 | 09:03 am
- ACADIA Pharmaceuticals To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4, 2013 - Business Wire 02.25.13 | 09:02 am
- ACADIA Pharmaceuticals To Present At The 15th Annual BIO CEO & Investor Conference On February 12, 2013 - Business Wire 02.05.13 | 09:02 am
- ACADIA Pharmaceuticals Announces Election Of Stephen R. Biggar To Its Board Of Directors - Business Wire 01.22.13 | 09:01 am
- ACADIA Pharmaceuticals To Receive Funding From Fast Forward And EMD Serono For Multiple Sclerosis Program - Business Wire 12.20.12 | 08:12 am
- ACADIA Pharmaceuticals To Present At The Oppenheimer 23rd Annual Healthcare Conference Today, December 12, 2012 - Business Wire 12.12.12 | 12:12 pm
Partner Headlines for ACAD
- Thursday's BioPharma Trade Movers - Seeking Alpha 04.18.13 | 09:04 am
- Pre-Market Most Active for Apr 11, 2013 : PCS, RAD, SGYP, INFI, MSFT, ACAD, RLGY, QQQ, FTNT, NOK, BAC, HPQ - NASDAQ 04.11.13 | 12:04 pm
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Mid-Day Market Update: Herman Miller Surges On Upbeat Earnings, Scholastic Falls - Benzinga 03.21.13 | 01:03 pm
- Pre-Market Most Active for Mar 21, 2013 : NOK, ORCL, SNY, BAC, BBRY, TOT, ACAD, CWT, CSCO, AWC, QQQ, ZNGA - NASDAQ 03.21.13 | 12:03 pm
- Acadia Forges Forward With Pimavanserin - Seeking Alpha 03.13.13 | 09:03 am
- After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP - NASDAQ 03.12.13 | 06:03 pm
- Biotech Weekly Recap: Loads Of Bullishness, 2 Giant Rallies, And Selling - Seeking Alpha 12.02.12 | 09:12 am
- After Hours Most Active for Nov 27, 2012 : ACAD, GMCR, CIG, DISH, EFII, NOK, T, BAC, JEF, MSFT, DTV, HAL - NASDAQ 11.27.12 | 09:11 pm
- Pre-Market Most Active for Nov 27, 2012 : ACAD, RAH, BAC, FB, NOK, SNE, GLW, SID, QQQ, AAPL, EBAY, ZNGA - NASDAQ 11.27.12 | 01:11 pm
